ArticleFrontiers in pharmacology2021

A FAK Inhibitor Boosts Anti-PD1 Immunotherapy in a Hepatocellular Carcinoma Mouse Model.

Yuhua Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.